- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
COPD patients at higher risk for future functional gastrointestinal disorders: Study
Taiwan: Chronic obstructive pulmonary disease (COPD) patients are at a higher risk for all three subtypes of functional gastrointestinal disorders (FGIDs): gastroesophageal reflux disease, irritable bowel syndrome, and functional dyspepsia, says a recent study.
The nationwide population-based study published in the journal Respiratory Medicine was conducted by Tzuo-Yun Lan, National Yang Ming Chiao Tung University, Taipei, Taiwan, and colleagues with an objective to determine the association between COPD and future development of FGIDs.
For this purpose, the researchers used Taiwan's National Health Insurance Research Database. The COPD cohort consisted of 4107 patients with COPD between 2000 and 2005. 12,321 age- and gender-matched patients without COPD were randomly selected for a comparison cohort. Tracking of the two cohorts was done for 5 years and observed for FGIDs occurrence. The results were validated using the operational definition of COPD in the Korean Health Insurance Review and Assessment Service database. The validation study confirmed the accuracy of definitions of COPD (83.5% sensitivity).
Based on the study, the researchers found the following:
· The adjusted hazard ratios (aHR) of FGIDs in patients with COPD were higher (aHR: 1.63) than that of the comparison patients.
· In the secondary analysis in which FGIDs were divided into gastroesophageal reflux disease, irritable bowel syndrome, and functional dyspepsia.
· Patients with COPD also had a higher risk for all three subtypes of FGIDs: irritable bowel syndrome (aHR: 1.55), gastroesophageal reflux disease (aHR: 2.10), and functional dyspepsia (aHR: 1.34).
· The results in validated COPD group were consistent with those in the unvalidated COPD group.
To conclude, "patients with chronic obstructive pulmonary disease appeared to be at higher risk for future functional gastrointestinal disorders."
The validation study confirmed the accuracy of definitions of COPD, they wrote.
Reference:
The study titled, "Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders," was published in the journal Respiratory Medicine.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751